Viewing Study NCT00604461


Ignite Creation Date: 2025-12-24 @ 12:42 PM
Ignite Modification Date: 2026-01-14 @ 8:48 PM
Study NCT ID: NCT00604461
Status: TERMINATED
Last Update Posted: 2017-03-23
First Post: 2008-01-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Carboplatin View
None Bevacizumab View
None Avastin View
None Pemetrexed View
None Alimta View